Recent news on Deferoxamine Mesylate

FTC Challenges Hospira/Mayne Pharma Deal  -  18 Jan 2007
PharmaLive.com (press release),Deferoxamine Mesylate. Injectable deferoxamine is an iron chelator used to treat acute iron poisoning or chronic iron overload.



Preapertura EE.UU.  May 10, 2006
...[+]. (MT) - --Teva Gets FDA OK of Deferoxamine Mesylate for Injection USP, to Ship Immediately... [+. MT) - Teva Beats Q4 EPS Estimates, Raises Dividend... [+. ... - Bolsamania.com





Teva Announces Approval of Deferoxamine Mesylate for Injection USP  Apr 2, 2006
...(Nasdaq:TEVA) announced today that the US Food and Drug Administration has granted approval for the Company's ANDA for Deferoxamine Mesylate for Injection USP ... - International News Service

Teva Receives FDA Approval For Deferoxamine Mesylate For Injection ...  Apr 2, 2006
...(TEVA | charts | news | Powerrating) said that the Food and Drug Administration has granted approval for its ANDA for Deferoxamine Mesylate for Injection USP ... - Trading Markets

FDA approves Teva's generic Desferal for injection  Apr 2, 2006
Teva’s Deferoxamine Mesylate treats iron intoxication and chronic iron overload due to transfusion-dependent anemia. Teva Pharmaceutical Industries Ltd. ... - Globes

Teva has FDA OK for generic Novartis injection  Apr 2, 2006
TEVA.TA: Quote, Profile, Research) said on Monday it received approval from the US Food and Drug Administration for deferoxamine mesylate for injection. ... - Reuters

Teva has FDA OK for generic Novartis injection  Apr 3, 2006
Industries Ltd. said on Monday it received approval from the US Food and Drug Administration for deferoxamine mesylate for injection. The ... - ABC News

Teva Cleared for Iron Treatment  Apr 3, 2006
Teva Pharmaceutical (TEVA:Nasdaq - commentary - research - Cramer's Take) got Food and Drug Administration clearance to sell deferoxamine mesylate for injection ... - TheStreet.com

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional